Human-in-the-loop artificial intelligence for drug-shortage recurrence-risk ranking and synthetic inventory-policy simulation using U.S. Food and Drug Administration Data
Background and motivation: Drug shortages disrupt patient care and hospital operations, while public records lack inventory and procurement data. Problem statement: This study separately evaluates whether U.S. Food and Drug Administration (FDA) shortage histories can rank 90-day recurrence risk and how a status-derived...